Name | moxidectin |
---|---|
Synonyms |
Equest
Vetdectin Oral Drench (1'R,2R,4E,4'S,5S,6S,8'R,10'E,13'R,14'E,16'E,20'R,21'R,24'S)-21',24'-Dihydroxy-4-(methoxyimino)-5,11',13',22'-tetramethyl-6-[(2E)-4-methyl-2-penten-2-yl]-3,4,5,6-tetrahydro-2'H-spiro[pyran-2,6'-[3,7,1 ;9]trioxatetracyclo[15.6.1.1.0]pentacosa[10,14,16,22]tetraen]-2'-one proheart bridged fused ring systems nomenclature: (2aE,4E,8E)-(5’S,6R,6’S,11R,13R,15S,17aR,20R,20aR,20bS)-6’-[(1E)-1,3-dimethylbut-1-enyl]-5’,6’,10,11,14,15,17a,20,20a,20b-decahydro-20,20b-dihydroxy-5’,6,8,19-tetramethylspiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2’-[2H]pyran]-4’,17(3’H,6H)-dione 4’-(E)-(O-methyloxime) ProHeart 6 Moxidectin HOUSE STANDARD Moxidectin (6R,23E,25S)-5-O-demethyl-28-deoxy-25-[(1E)-1,3-dimethyl-1-butenyl]-6,28-epoxy-23-(methoxyimino)milbemycin B Quest extended von Baeyer nomenclature: (10E,14E,16E)-(1R,4S,5’S,6R,6’S,8R,13R,20R,21R,24S)-6’-[(1E)-1,3-dimethylbut-1-enyl]-21,24-dihydroxy-5’,11,13,22-tetramethyl-(3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene)-6-spiro-2’-(tetrahydropyran)-2,4’-dione 4’-(E)-(O-methyloxime) |
Description | Moxidectin(ProHeart 6; CL301423; Cydectin) is an anthelmintic drug which kills parasitic worms (helminths), and is used for the prevention and control of heartworm and intestinal worms.IC50 value:Target: Anti-parasiticMoxidectin is a semisynthetic derivative of nemadectin, which is produced by fermentation by Streptomyces cyano-griseus. Moxidectin treats and controls some of the most common internal and external parasites by selectively binding to a parasite's glutamate-gated chloride ion channels. These channels are vital to the function of invertebrate nerve and muscle cells; when moxidectin binds to the channels, it disrupts neurotransmission, resulting in paralysis and death of the parasite. Studies of moxidectin show the side effects vary by animal and may be affected by the product’s formulation, application method and dosage. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 790.0±70.0 °C at 760 mmHg |
Melting Point | 132 °C |
Molecular Formula | C37H53NO8 |
Molecular Weight | 639.819 |
Flash Point | 431.6±35.7 °C |
Exact Mass | 639.377136 |
PSA | 116.04000 |
LogP | 8.43 |
Vapour Pressure | 0.0±6.2 mmHg at 25°C |
Index of Refraction | 1.581 |
Storage condition | 2-8°C |
Symbol |
GHS06, GHS09 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H400 |
Precautionary Statements | Missing Phrase - N15.00950417 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | T,N |
Risk Phrases | 25-50 |
Safety Phrases | 45-61-24/25 |
RIDADR | UN 2588 |
RTECS | PY5438800 |
Packaging Group | III |
Hazard Class | 6.1(b) |
HS Code | 29322090 |
~81% 113507-06-5 |
Literature: Tetrahedron Letters, , vol. 29, # 21 p. 2595 - 2598 |
~% 113507-06-5 |
Literature: Tetrahedron Letters, , vol. 29, # 21 p. 2595 - 2598 |
~% 113507-06-5 |
Literature: Tetrahedron Letters, , vol. 29, # 21 p. 2595 - 2598 |